Day: May 10, 2022

First Quarter 2022 Net Revenue of $63 Million, Up 26% from 2021Provides Second Quarter and Updated Full Year 2022 Outlook SAN FRANCISCO, May 10, 2022 (GLOBE NEWSWIRE) — Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with naturally derived materials to make better footwear and apparel products in a better way, today reported financial results for the first quarter of 2022 ended March 31, 2022. Quarter HighlightsFirst quarter 2022 net revenue increased 26% to $62.8 million compared to the first quarter of 2021 and increased 49% compared to the first quarter of 2020. First quarter 2022 gross profit increased 26% to $32.6 million compared to the first quarter of 2021, and first quarter 2022 gross margin was 51.9% compared to 52.0% in the first quarter of 2021. First quarter 2022 GAAP net loss of $21.9 million,...

HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its first quarter 2022 financial results. The announcement and financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call on Wednesday, May 11, 2022, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10164495/f1e7ad6d38. A recording of the webcast will be posted on the Investor Relations section of the website after the call is completed. About...

AUDUBON, Pa., May 10, 2022 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2022.Worldwide net sales were $230.5 million, an increase of 1.4% as compared to the first quarter of 2021 GAAP net income for the quarter was $38.1 million GAAP diluted earnings per share (“EPS”) was $0.37 and non-GAAP diluted EPS was $0.42 Non-GAAP adjusted EBITDA was $74.3 million, or 32.2% of net sales“Our first quarter results delivered top line growth in a period that faced headwinds of a difficult prior year comparative and COVID-19 deferrals of elective procedures, particularly in January and early February,” commented Dan Scavilla, President and CEO. “Importantly, US Spine sales recovered and had a record-breaking month...

Significant Increases in Revenue, CFR, Gross Profit, Operating Profit and Adjusted EBITDA Backlog Improved to $736.1 Million Reiterates 2022 Outlook First Quarter 2022 OverviewRevenue increased 17.4% to $102.2 million in 2021 Consulting Fee Revenue (“CFR”) rose 12.5% to $81.4 million from $72.4 million in the prior year period New contract awards were $88.0 million, resulting in a book-to-burn ratio of 1.08 Gross Profit up 16.9% to $31.8 million from $27.2 million in the prior year period Operating profit improved to $1.0 million from an operating loss of $(0.2) million in the prior year period; adjusted operating profit improved to $2.4 million from adjusted operating profit of $0.2 million Net loss narrowed to $(0.5) million, or $(0.01) per diluted share, from a net loss of $(2.7) million, or $(0.05) per diluted share in the prior...

Achieved Record Revenues of more than $43 Million, a 42.7% Increase YoY Three New Patents Issued; Now Five Orange-Book Listed Patents for FIRDAPSE® Significant Cash Position of $198 Million and No Funded Debt Advanced Plans to Diversify and Invest in Innovative Rare Disease Opportunities Reaffirms FY 2022 Total Revenue Guidance of $195 Million to $205 Million Company to Host a Conference Call and Webcast on May 11, 2022, at 8:30 AM ET CORAL GABLES, Fla., May 10, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today reported financial results for the first quarter 2022 and provided a corporate update. “I am proud of Catalyst’s...

HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the industrial and energy sectors, today announced results for the first quarter 2022. FIRST QUARTER 2022 SUMMARY (as compared to the first quarter 2021)Revenue of $28.7 million, 20.6% increase y/y Net loss from Continuing Operations of $5.0 million, $2.6 million increase y/y Non-GAAP EBITDA loss from Continuing Operations of $3.7 million, $2.6 million increase y/y Operating income for Services Division of $1.2 million, $0.9 million increase y/y Non-GAAP EBITDA for Services Division of $1.5 million, $1.1 million increase y/y Cash balance of $42.8 million at March 31, 2022Consolidated revenue for the first quarter 2022 was $28.7 million, compared to $23.8 million...

On Track for Several Milestones in 2022, and Supported by Strong Balance Sheet from Upsized Initial Public OfferingContinued Progress Advancing Epetraborole Clinical Program with Enrollment for Pivotal Phase 2/3 Trial in Treatment-Refractory MAC Lung Disease Expected to Begin in First Half of 2022AN2 Board Strengthened through Appointment of Key Industry ExecutivesMENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) — AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the quarter ended March 31, 2022. “Over the past several months, we made significant progress on many key initiatives, executed a successful upsized IPO, strengthened our board with new...

– Strong Start to 2022 with 10% Revenue Growth, 13% Adjusted EBITDA Growth, and Record Backlog – – Completed Strategic Acquisitions of TranSmart Technologies and 1 Alliance Geomatics – – Reaffirms 2022 Outlook for Revenue and Adjusted EBITDA – AUSTIN, Texas, May 10, 2022 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading infrastructure and environmental services provider, announced today results for the first quarter ended April 1, 2022. First Quarter 2022 Highlights:(all comparisons versus the prior-year period unless otherwise noted)Gross revenue grew 9.7% to $135.2 million, driven by 6% organic growth and the contribution from acquisitions. Net loss was $4.4 million. Adjusted net income (2) was $0.9 million, or $0.02 per share, which...

Revenue of $776 million in the First Quarter, up 7% Year-over-Year Core Revenue Grew 9% to $735 million Quarterly Cash Flow From Operating Activities of $65 millionSAN ANTONIO, May 10, 2022 (GLOBE NEWSWIRE) — Rackspace Technology, Inc. (Nasdaq: RXT), a leading end-to-end multicloud technology solutions company, today announced results for its first quarter ended March 31, 2022. Kevin Jones, Chief Executive Officer, commented, “Rackspace Technology benefits from secular tailwinds in a cloud market that shows no signs of slowing. In the first quarter alone, our cloud hyperscaler partners added $10 billion of new cloud revenue. All of this new cloud revenue represents customers moving to the cloud, grappling with change, and needing help on their journey. And Rackspace Technology is extremely well-positioned to be their partner...